A breakthrough in life-saving medical technology has arrived. The U.S. Food and Drug Administration (FDA) has officially ...

Drug-coated balloon catheters are specialized medical devices used primarily for expanding narrowed coronary arteries by delivering drugs during the dilation process, aimed at preventing restenosis ...

Silver Spring, Md Thursday, December 26, 2024, 11:00 Hrs [IST] ...

The single-use product is surgically implanted for arterial replacement and repair after a traumatic injury to the extremity.

Merit Medical Systems, Inc. MMSI recently announced the FDA's premarket approval for the WRAPSODY Cell-Impermeable ...

Humacyte stock has dropped 46% since July, mainly due to FDA review delays. Check out why I downgraded HUMA stock from "buy" ...

Analyst Michael Petusky from Barrington maintained a Buy rating on Merit Medical Systems (MMSI – Research Report) and keeping the price target ...

In partnership with Dr Bart Dolmatch at Palo Alto Medical Foundation, the company developed the device in 2010.

The U.S. Food and Drug Administration approved Symvess, the first acellular tissue engineered vessel indicated for use in ...

With approval, the company can begin commercializing the device in the U.S. in 2025.

Merit Medical Systems (MMSI) has received FDA approval for its WRAPSODY Cell-Impermeable Endoprosthesis device for the treatment of dialysis patients. Read more here.

Unique cell-impermeable1 design extends life-saving treatment for dialysis patientsMerit to host a WRAPSODY informational call on January 28, ...